Meersch M, Küllmar M, Schmidt C, Gerss J, Weinhage T, Margraf A, Ermet T, Kellum JA, Zarbock A. Long-term clinical outcomes after early initiation of RRT in critically III patients with AKI. J Am Soc Nephrol. 2017 Dec 1. poi: ASN.2017060694. doi: 10.1681/ASN.2017060694. PMID: 29196304
Walscheid K, Weinhage T, Foell D, Heinz C, Kasper M, Heiligenhaus A. Effect of Adalimumab on peripheral blood mononuclear cells in non-infectious uveitis. Ocul Immunol Inflamm. 2017 Oct 11:1-8. doi: 10.1080/09273948.2017.1374415. PMID: 29020495
Walscheid K, Neekamp L, Heiligenhaus A, Weinhage T, Holzinger D, Heinz C, Kasper M, Foell D. Peripheral blood monocytes reveal am activated phenotype in pediatric uveitis. Clin Immunol. 2017 Sept 15. pii: S1521-6616(17)30425-4. doi: 10.1016/j.clim.2017.09.014. PMID: 28923439
Knieper AM, Klotsche J, Lainka E, Berger T, Dressler F, Jansson AF, Rietschel C, Oommen PT, Berendes R, Niehues T, Neudorf U, Foell D, Wittkowski H, Kallinich T. Familial Mediterranean fever in children and adolescents: factors for colchicine dosage and predicting parameters for dose increase. Rheumatology. 2017 Sept (9): 1597-1606. Doi: 10.1093/rheumatology/kex222. PMID: 28859329
Belelli E, Passarelli C, Pardeo M, Holzinger D, De Benedetti F, Insalaco A. Haematological involvement associated with a mild autoinflammatory phenotype, in two patients carrying the E250K mutation of PSTPIP1. Clin Exp Rheumatol. 2017 Jun 19. PMID: 28628471
Kallinich T, Orak B, Wittkowski H. Role of genetics in familial Mediterranean fever. Zeitschrift für Rheumatol. 2017 May (4): 303-312. doi: 10.1007/s00393-017-0265-9. PMID: 28154935
Ombrello MJ, Arthur VL, Remmers EF, Hinks A, Tachmazidou I, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rosen-Wolff A, Minden K, Tenbrock K, Demirkaya E, Cobb J, Baskin E, Signa S, Shuldiner E, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcon-Riquelme ME, Docampo E, Estivill X, Gül A; British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis (ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group., Langefeld CD, Thompson S, Zeggini E, Kastner DL, Woo P, Thomson W. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other froms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann Rheum Dis. 2017 May;76(5):906-913. doi: 10.1136/annrheumdis-2016-210324. PMID: 27927641
Wittkowski H, Hinze C, Haefner-Harms S, Oji V, Masjosthusmann K, Monninger M, Grenzebach U, Foell D. Munchausen by proxy syndrome mimicking systemic autoinflammatory disease: case report and review of the literature. Pediatric Rheumatol Online J. 2017 Apr 5;15(1):19. doi: 10.1186/s12969-017-0152-6. PMID: 28381287
Morishita KA, Moorthy LN, Lubieniecka JM, Twilt M, Yeung RS, Toth MB, Shenoi S, Ristic G, Nielson SM, Luqmani RA, Li SC, Lee T, Lawson EF, Kostik MM, Klein-Gitelman M, Huber AM, Hersh AO, Foell D, Elder ME, Eberhard BA, Dancey P, Charuvanij S, Benseler SM, Cabral DA; for ARChiVe Investigators Network within the PedVas Initiative. Arthritis Rheumatol. 2017 Mar 28. doi: 10.1002/art.40112. PMID: 28371513
Kessel C, Lippitz K, Weinhage T, Hinze C, Wittkowski H, Holzinger D, Fall N, Grom AA, Gruen N, Foell D. Pro-inflammatory cytokine environments can drive IL-17 over-expression by yðT cells in systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2017 Mar 15. doi: 10.1002/art.40099.
Letkemann R, Wittkowski H, Antonopoulos A, Podskabi T, Haslam SM, Föll D, Dell A, Marquardt T. Partial correction of neutrophil disfunction by oral galactose therapy in glycogen storage disease type Ib. Int Immunopharmacol. 2017 Mar; 44:216-225. doi: 10.1016/j.intimp.2017.01.020. Epub 2017 Jan 23.
Horneff G, Peitz J, Kekow J, Foell D. Canakinumab for first line steroid-free treatment in a child with systemic-onset juvenile idiopathic arthritis. Scand J Rheumatol. 2017 Mar 7:1-2. do: 10.1080/03009742.2017.1288827. PMID: 28266235
Hinze C, Foell D. Autoinflammatory diseases: New diagnostic criteria for CAPS - turning horses into zebras? Nat Rev Rheumatol. 2017 Jan;13(1):7-8. doi: 10.1038/nrrheum.2016.201. PMID: 27928157